Australia, Dec. 10 -- Regeneron Pharmaceuticals Inc., owns the trademark (2486762) for 'EYEGM' till Sept. 30, 2034.
Status: registered:
Registered/protected
Classes: 42 [Platform as a service (PAAS) featuring computer software platforms for genetic research and gene therapy; providing a database of information relating to diseases and genetic information] and 42 [Platform as a service (PAAS) featuring computer software platforms for genetic research and gene therapy;providing a database of information relating to diseases and genetic information]
Type of Mark: Word
Date of Acceptance: Oct. 2
Registration Advertised: Dec. 9
For further details contact PHILLIPS ORMONDE FITZPATRICK.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2486762.
Disclaimer: Curated by HT Syndication.
